GU19 AntiPDL1 TKI combo setting new SoC in 1L mRCC full data showdown in NEJM$MRK Keynote426 httpswww.nejm.orgdoifull10.1056NEJMoa1816714queryfeaturedhomeÂ$PFE Javelin Renal 101httpswww.nejm.orgdoifull10.1056NEJMoa18160

#GU19 Anti-PD-(L)1 + TKI combo setting new SoC in 1L mRCC, full data showdown in NEJM $MRK Keynote-426 https://www.nejm.org/doi/full/10.1056/NEJMoa1816714?query=featured_home … $PFE Javelin Renal 101 https://www.nejm.org/doi/full/10.1056/NEJMoa18160

17:44 EST 16 Feb 2019 | Andy Biotech

#GU19 Anti-PD-(L)1 + TKI combo setting new SoC in 1L mRCC, full data showdown in NEJM $MRK Keynote-426 https://www.nejm.org/doi/full/10.1056/NEJMoa1816714?query=featured_home … $PFE Javelin Renal 101 https://www.nejm.org/doi/full/10.1056/NEJMoa1816047?query=featured_home … $MRK CR only 5.8% in KN-426, gives $BMY (~10% CR in CM-214) some breathing room https://www.nejm.org/doi/full/10.1056/NEJMe1900887 … pic.twitter.com/wqhclaCsKS

More From BioPortfolio on "#GU19 Anti-PD-(L)1 + TKI combo setting new SoC in 1L mRCC, full data showdown in NEJM $MRK Keynote-426 https://www.nejm.org/doi/full/10.1056/NEJMoa1816714?query=featured_home … $PFE Javelin Renal 101 https://www.nejm.org/doi/full/10.1056/NEJMoa18160"